Chong Hwa Kim
Overview
Explore the profile of Chong Hwa Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
639
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hong S, Kim W, Kang E, Jeong I, Kim C, Lee K, et al.
Diabetes Obes Metab
. 2024 Dec;
27(3):1242-1250.
PMID: 39703109
Aims: This study evaluated the efficacy and safety of a combination of phentermine and delayed-release topiramate (PHEN/TPM CR) versus placebo as an adjunct to standard lifestyle recommendations in Korean adults....
2.
Kim N, Lee J, Chon S, Yu J, Jeong I, Lim S, et al.
Endocrinol Metab (Seoul)
. 2024 Aug;
39(5):722-731.
PMID: 39174014
Backgruound: Atherogenic dyslipidemia, which is frequently associated with type 2 diabetes (T2D) and insulin resistance, contributes to the development of vascular complications. Statin therapy is the primary approach to dyslipidemia...
3.
Moon J, Kang S, Choi J, Lee K, Moon J, Chon S, et al.
Diabetes Metab J
. 2024 Aug;
48(4):546-708.
PMID: 39091005
No abstract available.
4.
Kwak S, Han K, Kim E, Choi S, Won J, Yu J, et al.
Diabetes Obes Metab
. 2024 Jul;
26(10):4203-4212.
PMID: 39054871
Aims: To evaluate the long-term safety and efficacy of enavogliflozin monotherapy (0.3 mg/day) in individuals with type 2 diabetes mellitus (T2DM). Materials And Methods: Following a 24-week randomized, double-blind treatment...
5.
Yang Y, Kim N, Baek J, Ko S, Son J, Lee S, et al.
Diabetes Metab J
. 2024 Jan;
48(2):279-289.
PMID: 38273793
Backgruound: Recent diabetes management guidelines recommend that sodium-glucose cotransporter 2 inhibitors (SGLT2is) or glucagon-like peptide 1 receptor agonists (GLP-1RAs) with proven cardiovascular benefits should be prioritized for combination therapy in...
6.
Choi J, Lee K, Moon J, Chon S, Kim D, Kim H, et al.
Diabetes Metab J
. 2023 Oct;
47(5):575-594.
PMID: 37793979
In May 2023, the Committee of Clinical Practice Guidelines of the Korean Diabetes Association published the revised clinical practice guidelines for Korean adults with diabetes and prediabetes. We incorporated the...
7.
Kim Y, Lee J, Lee C, Chung C, Lee J, Ko S, et al.
J Diabetes Investig
. 2022 Jul;
13(11):1852-1860.
PMID: 35779248
Aims/introduction: We investigated the classification of diabetic peripheral neuropathy (DPN) patients by subjective symptoms, and identification of the relationship between the patterns and intensities of symptoms and the clustered groups...
8.
Kim B, Kim C, Min Y
Endocrinol Metab (Seoul)
. 2021 Sep;
36(4):909-911.
PMID: 34474520
No abstract available.
9.
Hur K, Moon M, Park J, Kim S, Lee S, Yun J, et al.
Diabetes Metab J
. 2021 Aug;
45(4):461-481.
PMID: 34352984
The Committee of Clinical Practice Guidelines of the Korean Diabetes Association (KDA) updated the previous clinical practice guidelines for Korean adults with diabetes and prediabetes and published the seventh edition...
10.
Kim B, Kang S, Kang J, Kang S, Kim K, Kim K, et al.
J Obes Metab Syndr
. 2021 May;
30(2):81-92.
PMID: 34045368
Obesity is a prevalent and complex disease. The prevalence of obesity in Korea increased from 29.7% in 2010 to 35.7% in 2018, with the prevalence of abdominal obesity being 23.8%...